Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17399
Country/Region: Zambia
Year: 2017
Main Partner: John Snow, Inc
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: $15,603,033

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 93,724
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 11
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 1,165
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 1,697
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 2,377
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 291
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 1,668
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 842
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 829
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 264
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 264
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 252
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 248
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 389
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 383
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 98
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 96
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 426
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 2,443
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 1,246
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 1,235
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 449
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 433
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 794
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 599
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 772
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 581
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 195
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 194
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 148
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 163
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 83
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 82
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 1,264
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 1,288
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 1,581
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 1,664
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 994
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 1,002
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 152
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 154
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 1,788
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 13
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 10
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 13
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 10
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 59
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 58
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 31
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 31
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 201
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 1,151
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 575
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 575
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 2,433
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 2,460
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 2,434
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 2,462
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 9,429
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 9,655
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 1,888
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 1,931
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2018 3,061
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 5,049
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 4,997
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 6,563
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 27
HTS_TST Sum of Test Result disaggregates 2018 8,000
HTS_TST_POS By Test Result: Positive 2018 8,000
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 52
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 168
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 292
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 42
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 25
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 26
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 53
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 55
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 130
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 110
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 80
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 138
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 103
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 33
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 33
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 54
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 25
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 175
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 89
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 147
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 138
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 95
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 55
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 54
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 61
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 29
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 29
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 157
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 129
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 157
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 129
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 1,667
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 1,443
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 333
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 289
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2018 30
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 105
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 154
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 650
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,674
PMTCT_ART New on ART 2018 91
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,765
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 13,149
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,546
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,336
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 133
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 68
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 9
PMTCT_STAT By Age (Numerator): 10-14 2018 42
PMTCT_STAT By Age (Numerator): 15-19 2018 2,684
PMTCT_STAT By Age (Numerator): 20-24 2018 4,136
PMTCT_STAT By Age (Numerator): 25-49 2018 6,285
PMTCT_STAT By Number of known positives: 15-19 2018 33
PMTCT_STAT By Number of known positives: 20-24 2018 141
PMTCT_STAT By Number of known positives: 25-49 2018 592
PMTCT_STAT By Number of new negative: 10-14 2018 41
PMTCT_STAT By Number of new negative: 15-19 2018 2,570
PMTCT_STAT By Number of new negative: 20-24 2018 3,742
PMTCT_STAT By Number of new negative: 25-49 2018 5,244
PMTCT_STAT By Number of new positives: 15-19 2018 79
PMTCT_STAT By Number of new positives: 20-24 2018 254
PMTCT_STAT By Number of new positives: 25-49 2018 447
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 13,149
PMTCT_STAT_den By Age (Denominator): <15-19 2018 2,968
PMTCT_STAT_den By Age (Denominator): 10-14 2018 32
PMTCT_STAT_den By Age (Denominator): 20-24 2018 4,532
PMTCT_STAT_den By Age (Denominator): 25-49 2018 6,928
PP_PREV Age/sex: 15-19 Female 2018 28,212
PP_PREV Age/sex: 15-19 Male 2018 28,217
PP_PREV Age/sex: 20-24 Female 2018 28,216
PP_PREV Age/sex: 20-24 Male 2018 37,628
PP_PREV Age/sex: 25-49 Female 2018 28,217
PP_PREV Age/sex: 25-49 Male 2018 37,623
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 188,113
PP_PREV Sum of Age/Sex disaggregates 2018 188,113
PrEP_NEW Female 20-24 2018 400
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2018 400
TX_CURR Age/Sex: <1 2018 208
TX_CURR Age/Sex: <1-9 2018 1,792
TX_CURR Age/Sex: 10-14 Female 2018 312
TX_CURR Age/Sex: 10-14 Male 2018 216
TX_CURR Age/Sex: 15-19 Female 2018 3,412
TX_CURR Age/Sex: 15-19 Male 2018 2,279
TX_CURR Age/Sex: 20-24 Female 2018 1,736
TX_CURR Age/Sex: 20-24 Male 2018 1,626
TX_CURR Age/Sex: 25-49 Female 2018 10,278
TX_CURR Age/Sex: 25-49 Male 2018 8,348
TX_CURR Age/Sex: 50+ Female 2018 1,713
TX_CURR Age/Sex: 50+ Male 2018 1,144
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 33,507
TX_CURR Sum of age/sex disaggregates 2018 5,691
TX_NEW By Age/Sex: <1 2018 140
TX_NEW By Age/Sex: 1-9 2018 720
TX_NEW By Age/Sex: 10-14 Female 2018 692
TX_NEW By Age/Sex: 10-14 Male 2018 671
TX_NEW By Age/Sex: 15-19 Female 2018 1,239
TX_NEW By Age/Sex: 15-19 Male 2018 1,219
TX_NEW By Age/Sex: 20-24 Female 2018 1,333
TX_NEW By Age/Sex: 20-24 Male 2018 1,285
TX_NEW By Age/Sex: 25-49 Female 2018 2,722
TX_NEW By Age/Sex: 25-49 Male 2018 3,581
TX_NEW By Age/Sex: 50+ Female 2018 1,201
TX_NEW By Age/Sex: 50+ Male 2018 1,188
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 16,008
TX_NEW People in prisons and other enclosed settings 2018 1,576
TX_NEW Sum of Age/Sex disaggregates 2018 15,131
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 951
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 953
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,029
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,036
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 13,963
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 15,022
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,107
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,114
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,400
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,401
VMMC_CIRC By Age: 10-14 2018 7,147
VMMC_CIRC By Age: 15-19 2018 12,009
VMMC_CIRC By Age: 20-24 2018 12,009
VMMC_CIRC By Age: 25-29 2018 12,010
VMMC_CIRC By Age: 30-49 2018 4,861
VMMC_CIRC By circumcision technique: Surgical VMMC 2018 48,188
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 48,036
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 48,036
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 31,165